Compare DSL & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | DSL | SSII |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | N/A |
| Metric | DSL | SSII |
|---|---|---|
| Price | $11.16 | $5.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 784.6K | 87.7K |
| Earning Date | 01-01-0001 | 10-28-2025 |
| Dividend Yield | ★ 11.81% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,066,457.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 158.36 |
| 52 Week Low | $10.58 | $3.02 |
| 52 Week High | $12.92 | $22.42 |
| Indicator | DSL | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 34.50 | 42.83 |
| Support Level | $11.12 | $4.96 |
| Resistance Level | $11.23 | $6.00 |
| Average True Range (ATR) | 0.08 | 0.46 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 22.22 | 43.40 |
DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.